{"id":5516,"date":"2023-11-09T06:45:26","date_gmt":"2023-11-09T12:45:26","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5516"},"modified":"2025-06-27T11:28:27","modified_gmt":"2025-06-27T16:28:27","slug":"nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/","title":{"rendered":"Nanoscope Therapeutics \u304c\u7b2c 4 \u56de\u5e74\u6b21\u4e7e\u5f0f AMD \u6cbb\u7642\u958b\u767a\u30b5\u30df\u30c3\u30c8\u3067\u767a\u8868"},"content":{"rendered":"
\n

<\/h1>\n<\/div>\n
\n
\n
\n
\n

\u30c0\u30e9\u30b9<\/span><\/span>,\u00a02023 \u5e74 11 \u6708 9 \u65e5<\/span><\/span>\u00a0 \u2014 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u304a\u3088\u3073\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\uff08AMD\uff09\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3059\u308b\u81e8\u5e8a\u6bb5\u968e\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306f\u672c\u65e5\u3001\u535a\u58eb\u304c\u6b21\u306e\u3088\u3046\u306b\u767a\u8868\u3057\u305f\u3002\u00a0\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3<\/span>\u3001\u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005\u306f\u30d1\u30cd\u30eb\u306b\u53c2\u52a0\u3057\u3001\u8b1b\u6f14\u3057\u307e\u3059\u3002\u00a04\u756a\u76ee<\/sup>\u00a0\u5e74\u6b21\u30c9\u30e9\u30a4 AMD \u6cbb\u7642\u958b\u767a\u30b5\u30df\u30c3\u30c8<\/a>\u00a0\u304b\u3089\u8d77\u3053\u308b\u00a02023\u5e7411\u670814\u65e5\uff5e16\u65e5<\/span>\u00a0\u3067\u00a0\u30de\u30b5\u30c1\u30e5\u30fc\u30bb\u30c3\u30c4\u5dde\u30dc\u30b9\u30c8\u30f3<\/span>\u3002\u30d1\u30cd\u30eb\u304a\u3088\u3073\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n

\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0\u8a8d\u77e5\u3055\u308c\u305f\u75be\u60a3\u30e2\u30c7\u30eb\u3092\u6301\u305f\u306a\u3044\u4e7e\u6027AMD\u306e\u9650\u754c\u3092\u514b\u670d\u3059\u308b
\u30bb\u30c3\u30b7\u30e7\u30f3\uff1a\u00a0<\/b>\u30c9\u30e9\u30a4\u578b\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\u306e\u751f\u4f53\u5185\u304a\u3088\u3073\u751f\u4f53\u5916\u30e2\u30c7\u30eb\u3092\u6700\u9069\u5316\u3057\u3066\u6709\u52b9\u6027\u3092\u5411\u4e0a\u3055\u305b\u308b\u65b9\u6cd5
\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b>2023 \u5e74 11 \u6708 15 \u65e5<\/span>
\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b>\u5348\u524d11\u6642\uff08\u6771\u90e8\u6a19\u6e96\u6642\uff09<\/span>
\u4f4d\u7f6e\uff1a\u00a0<\/b>\u30d2\u30eb\u30c8\u30f3 \u30dc\u30b9\u30c8\u30f3 \u30ed\u30fc\u30ac\u30f3 \u30a8\u30a2\u30dd\u30fc\u30c8<\/p>\n

\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u4e2d\u3001\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u3001\u4e7e\u6027AMD\u306b\u95a2\u9023\u3059\u308b\u52d5\u7269\u30e2\u30c7\u30eb\u306e\u958b\u767a\u304c\u4f9d\u7136\u3068\u3057\u3066\u9069\u5207\u306a\u8ab2\u984c\u3067\u3042\u308b\u7406\u7531\u3092\u5f37\u8abf\u3057\u307e\u3059\u3002\u540c\u6c0f\u306f\u307e\u305f\u3001\u4e7e\u6027\u578bAMD\u6cbb\u7642\u85ac\u306e\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u3088\u308a\u826f\u304f\u4f1d\u3048\u308b\u305f\u3081\u306b\u3001\u524d\u81e8\u5e8a\u8a66\u9a13\u306b\u3055\u3089\u306b\u591a\u304f\u306eNHP\u3092\u7d44\u307f\u8fbc\u3080\u65b9\u6cd5\u3092\u6a21\u7d22\u3059\u308b\u4e88\u5b9a\u3060\u3002<\/p>\n

\u30bf\u30a4\u30c8\u30eb\uff1a\u00a0<\/b>\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\u306e\u30ec\u30fc\u30b6\u30fc\u9001\u9054\u306b\u3088\u308b\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30af\u30b9\u306e\u8996\u529b\u56de\u5fa9\u3092 GA \u306b\u62e1\u5927
\u30bb\u30c3\u30b7\u30e7\u30f3\uff1a\u00a0<\/b>\u30c9\u30e9\u30a4\u578bAMD\u6cbb\u7642\u85ac\u306e\u63d0\u4f9b\u3092\u6539\u5584\u3059\u308b\u305f\u3081\u306e\u6700\u65b0\u306e\u9032\u6b69\u3092\u8abf\u67fb\u3059\u308b
\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b>2023 \u5e74 11 \u6708 16 \u65e5<\/span>
\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b>\u6771\u90e8\u6a19\u6e96\u6642\u9593\u5348\u5f8c 4 \u6642<\/span>
\u4f4d\u7f6e\uff1a\u00a0<\/b>\u30d2\u30eb\u30c8\u30f3 \u30dc\u30b9\u30c8\u30f3 \u30ed\u30fc\u30ac\u30f3 \u30a8\u30a2\u30dd\u30fc\u30c8<\/p>\n

\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u8b1b\u6f14\u306e\u4e2d\u3067\u3001\u30d2\u30c8\u3067\u5f97\u3089\u308c\u305f\u6982\u5ff5\u5b9f\u8a3c\u30c7\u30fc\u30bf\u306b\u57fa\u3065\u304d\u3001\u5149\u907a\u4f1d\u5b66\u3092\u7528\u3044\u3066\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\u60a3\u8005\u306e\u8996\u529b\u6539\u5584\u3092\u56f3\u308b\u53ef\u80fd\u6027\u306b\u3064\u3044\u3066\u8ad6\u3058\u308b\u3068\u3068\u3082\u306b\u3001\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u306e\u30ec\u30fc\u30b6\u30fc\u7167\u5c04\u306b\u95a2\u3059\u308b\u6700\u65b0\u306e\u524d\u81e8\u5e8a\u30c7\u30fc\u30bf\u306b\u3064\u3044\u3066\u3082\u8a55\u4fa1\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u3053\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u69d8\u3005\u306a\u7db2\u819c\u5909\u6027\u75be\u60a3\u306e\u6cbb\u7642\u306b\u5fdc\u7528\u3067\u304d\u308b\u53ef\u80fd\u6027\u306b\u3064\u3044\u3066\u3082\u8b70\u8ad6\u3057\u307e\u3059\u3002.<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
<\/b>Nanoscope Therapeutics \u306f\u3001\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306b\u3088\u3063\u3066\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u305b\u305a\u8996\u529b\u3092\u56de\u5fa9\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306e\u4e3b\u8981\u8cc7\u7523\u3067\u3042\u308b MCO-010 \u306f\u3001\u7c73\u56fd\u3067\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3092\u5bfe\u8c61\u3068\u3057\u305f RESTORE \u7b2c 2b \u76f8\u591a\u65bd\u8a2d\u7121\u4f5c\u70ba\u5316\u4e8c\u91cd\u30de\u30b9\u30af\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u6700\u8fd1\u5831\u544a\u3057\u307e\u3057\u305f (NCT04945772<\/a>\uff09\u3002\u540c\u793e\u306f\u6700\u8fd1\u3001\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f MCO-010 \u7642\u6cd5\u306e\u7b2c 2 \u76f8 STARLIGHT \u8a66\u9a13\u306e\u305f\u3081\u306e\u7814\u7a76\u7d42\u4e86\u6642\u306e\u8a2a\u554f\u3082\u5b8c\u4e86\u3057\u307e\u3057\u305f (NCT05417126<\/a>\uff09\u3002 MCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3068\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u306e\u4e21\u65b9\u306b\u5bfe\u3057\u3066FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u304a\u3088\u3073FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001AMD \u306b\u7d9a\u767a\u3059\u308b\u5730\u7406\u7684\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u30ec\u30fc\u30b6\u30fc\u306b\u3088\u308b MCO-020 \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
212-600-1902
PR@nanostherapeutics.com<\/a><\/p>\n

\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"

DALLAS,\u00a0Nov. 9, 2023\u00a0 \u2014 Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that Dr.\u00a0Samarendra Mohanty, President and Chief Scientific Officer will participate in a panel and present at the\u00a04th\u00a0Annual Dry AMD Therapeutic Development Summit\u00a0taking place from\u00a0November 14-16, 2023\u00a0in\u00a0Boston, Massachusetts. Details for the panel and presentation are as follows: Title:\u00a0Overcoming the Limitations of Dry AMD not having a Recognised Disease ModelSession:\u00a0Navigating how to Optimize Current Dry AMD In Vivo & In Vitro Models to Improve EfficacySession Date:\u00a0November 15, 2023Session Time:\u00a011:00 a.m. E.T.Location:\u00a0Hilton Boston Logan Airport During the panel discussion, Dr. Mohanty will highlight the reasons why developing a […]<\/p>\n","protected":false},"author":6,"featured_media":5521,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5516","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics to Present at the 4th Annual Dry AMD Therapeutic Development Summit - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics to Present at the 4th Annual Dry AMD Therapeutic Development Summit - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-09T12:45:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:28:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_LI_Dry-AMD-Summit.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/09\/NSCOPE_LI_Barone_final2.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics to Present at the 4th Annual Dry AMD Therapeutic Development Summit\",\"datePublished\":\"2023-11-09T12:45:26+00:00\",\"dateModified\":\"2025-06-27T16:28:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/\"},\"wordCount\":386,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/NSCOPE_LI_Dry-AMD-Summit.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/\",\"name\":\"Nanoscope Therapeutics to Present at the 4th Annual Dry AMD Therapeutic Development Summit - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/NSCOPE_LI_Dry-AMD-Summit.jpg\",\"datePublished\":\"2023-11-09T12:45:26+00:00\",\"dateModified\":\"2025-06-27T16:28:27+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/NSCOPE_LI_Dry-AMD-Summit.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/NSCOPE_LI_Dry-AMD-Summit.jpg\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/09\\\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics to Present at the 4th Annual Dry AMD Therapeutic Development Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7b2c4\u56de\u30c9\u30e9\u30a4\u578b\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\u6cbb\u7642\u958b\u767a\u30b5\u30df\u30c3\u30c8\u3067\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u5b9f\u65bd - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics to Present at the 4th Annual Dry AMD Therapeutic Development Summit - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2023-11-09T12:45:26+00:00","article_modified_time":"2025-06-27T16:28:27+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_LI_Dry-AMD-Summit.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/09\/NSCOPE_LI_Barone_final2.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics to Present at the 4th Annual Dry AMD Therapeutic Development Summit","datePublished":"2023-11-09T12:45:26+00:00","dateModified":"2025-06-27T16:28:27+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/"},"wordCount":386,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_LI_Dry-AMD-Summit.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/","url":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7b2c4\u56de\u30c9\u30e9\u30a4\u578b\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\u6cbb\u7642\u958b\u767a\u30b5\u30df\u30c3\u30c8\u3067\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u5b9f\u65bd - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_LI_Dry-AMD-Summit.jpg","datePublished":"2023-11-09T12:45:26+00:00","dateModified":"2025-06-27T16:28:27+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_LI_Dry-AMD-Summit.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_LI_Dry-AMD-Summit.jpg","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2023\/11\/09\/nanoscope-therapeutics-to-present-at-the-4th-annual-dry-amd-therapeutic-development-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics to Present at the 4th Annual Dry AMD Therapeutic Development Summit"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5516"}],"version-history":[{"count":3,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5516\/revisions"}],"predecessor-version":[{"id":9063,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5516\/revisions\/9063"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5521"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}